Fundies.
English

Segment disclosures

Company overview

Prime Medicine, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 16 retained observations 11 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=prme:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-301154000 USD20260806Open filing evidence
2026-01-01 – 2026-06-302010000 USD20260806Open filing evidence
2026-01-01 – 2026-03-31856000 USD20260507Open filing evidence
2025-01-01 – 2025-12-314632000 USD20260303Open filing evidence
2025-07-01 – 2025-09-301225000 USD20251107Open filing evidence
2025-01-01 – 2025-09-303794000 USD20251107Open filing evidence
2025-04-01 – 2025-06-301115000 USD20260806Open filing evidence
2025-01-01 – 2025-06-302569000 USD20260806Open filing evidence
2025-01-01 – 2025-03-311454000 USD20260507Open filing evidence
2024-01-01 – 2024-12-312983000 USD20260303Open filing evidence
2024-07-01 – 2024-09-30209000 USD20251107Open filing evidence
2024-01-01 – 2024-09-30800000 USD20251107Open filing evidence
2024-04-01 – 2024-06-300 USD20250807Open filing evidence
2024-01-01 – 2024-06-30591000 USD20250807Open filing evidence
2024-01-01 – 2024-03-31591000 USD20250508Open filing evidence
2023-01-01 – 2023-12-310 USD20250228Open filing evidence